ARTICLES

Filter  
Active filters 0
Remove
  

Refine your searches by:

Collections
Biology
Agronomy and forestry
Food and nutrition
Medicine / Sub specialtie
Zoology
Public health
Chemistry
Technology
Pure sciences
Research
all records (70)

Languages
English
Spanish
German
Portuguese
French

Countries
Indonesia
USA
Ukraine
Romania
Brazil
Turkey, Turkish Republic
India
Italy
Russia
Poland
all records (71)

Years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
all records (24)

Filter  
 
18.248  Articles
1 of 1.826 pages  |  10  records  |  more records»
Calix[4]arene are known to be a promising scaffold for designing inhibitors of protein tyrosine phosphatases.In this work calix[4]arene mono- and bis-a-hydroxymethylphosphonic acids have been tested in vitro for the inhibitory activity against some therap... see more

A new scoring function H1 recently developed for molecular docking has been tested on the complexes of protein tyrosine phosphatase 1B (PTP1B) from the PDB data bank and using docking of a set of inhibitors from the NIH database. The function is... see more

The protein tyrosine phosphatase (PTP) family is involved in multiple cellular functions and plays an important role in various pathological and physiological processes. In many chronic diseases, for example cancer, PTP is a potential therapeutic target f... see more

Previously, phosphonic acid derivatives of calix[4]arene and thiacalix[4]arene were found to be potential inhibitors of protein tyrosine phosphatase 1B. In the present paper, the inhibitory activity of unsubstituted sulfonyl-bridget calix[4]arene towards ... see more

Protein tyrosine kinases form an important target for a new class of anticancer drugs, the tyrosine kinase inhibitors (TKIs). Recently we demonstrated that sunitinib, an inhibitor of the membrane-associated vascular endothelial growth factor receptor (VEG... see more

Tyrosine kinase inhibitors are a class of chemotherapeutic drugs that target specific protein kinases. These tyrosine kinase inhibitors constitute a relatively new class of drugs which target for instance Bcr-Abl, Epidermal Growth Factor Receptor (EGFR) a... see more

Many potentially valuable drugs, including protein kinase inhibitors (PKI), risk being dropped from further development, without exploration of their clinical benefits, if early studies show these drugs to inhibit hERG channel and therefore, to have a pot... see more

1 of 1.826 pages  |  10  records  |  more records»